ANI Pharmaceuticals (ANIP)

[jeffqdhsr]

JTFM

I remember having the discussion as to whether efficacy was included in safety study , Not sure it was part of original study at all ? but may have been added in additional five year study. Again its difficult to comprehend how efficacy could have failed and there was so much emphasis on it when 4 mil scripts are still be written for low T in women.

I looked at Unimed and Solvay as it relates to stock holders benefiting Androgel, Lets just say Abbott did really well!

JMHO